WEBSTER BANK, N. A. - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 58 filers reported holding NYMOX PHARMACEUTICAL CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WEBSTER BANK, N. A. ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q2 2022$35,000
-65.3%
80,0000.0%0.01%
-58.3%
Q1 2022$101,000
-2.9%
80,0000.0%0.01%
+9.1%
Q4 2021$104,000
-37.0%
80,0000.0%0.01%
-38.9%
Q3 2021$165,000
+31.0%
80,0000.0%0.02%
+28.6%
Q2 2021$126,000
-18.7%
80,000
+14.3%
0.01%
-22.2%
Q1 2021$155,000
-10.9%
70,0000.0%0.02%
-10.0%
Q4 2020$174,000
+1.2%
70,0000.0%0.02%
-13.0%
Q3 2020$172,000
-19.2%
70,000
+16.7%
0.02%
-23.3%
Q2 2020$213,000
+52.1%
60,0000.0%0.03%
+30.4%
Q1 2020$140,000
+6.1%
60,0000.0%0.02%
+35.3%
Q4 2019$132,000
+20.0%
60,0000.0%0.02%
+13.3%
Q3 2019$110,000
+26.4%
60,0000.0%0.02%
+25.0%
Q2 2019$87,000
-26.3%
60,0000.0%0.01%
-29.4%
Q1 2019$118,000
+49.4%
60,0000.0%0.02%
+30.8%
Q4 2018$79,000
-46.6%
60,0000.0%0.01%
-38.1%
Q3 2018$148,000
-11.9%
60,000
+20.0%
0.02%
-12.5%
Q2 2018$168,000
-20.8%
50,0000.0%0.02%
-22.6%
Q1 2018$212,000
+28.5%
50,0000.0%0.03%
+34.8%
Q4 2017$165,000
-13.6%
50,0000.0%0.02%
-17.9%
Q3 2017$191,000
-13.2%
50,0000.0%0.03%
-15.2%
Q2 2017$220,000
+51.7%
50,000
+25.0%
0.03%
+50.0%
Q1 2017$145,000
+35.5%
40,0000.0%0.02%
+37.5%
Q4 2016$107,000
-17.7%
40,0000.0%0.02%
-15.8%
Q3 2016$130,000
+28.7%
40,000
+33.3%
0.02%
+26.7%
Q2 2016$101,000
+38.4%
30,0000.0%0.02%
+36.4%
Q1 2016$73,000
+10.6%
30,000
+50.0%
0.01%0.0%
Q4 2015$66,00020,0000.01%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q4 2020
NameSharesValueWeighting ↓
First Citizens Financial Corp 35,100$89,0000.08%
Geier Asset Management, Inc. 35,000$91,0000.07%
Patriot Financial Group Insurance Agency, LLC 43,250$107,0000.03%
Willow Creek Wealth Management Inc. 24,224$60,0000.02%
WEBSTER BANK, N. A. 70,000$174,0000.02%
Brown Advisory Securities, LLC 28,000$69,0000.01%
Cubic Asset Management, LLC 11,250$28,0000.01%
Tower Research Capital LLC (TRC) 25,613$64,0000.00%
GOFEN & GLOSSBERG LLC /IL/ 25,000$62,0000.00%
Sterling Investment Advisors, Ltd. 2,500$6,0000.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders